טוען...
A Site-Specifically Labeled Antibody-Drug Conjugate for Simultaneous Therapy and ImmunoPET
The conjugation of antibodies with cytotoxic drugs can alter their in vivo pharmacokinetics. As a result, the careful assessment of the in vivo behavior — and specifically the tumor-targeting properties — of antibody-drug conjugates represents a crucial step in their development. In order to facilit...
שמור ב:
| הוצא לאור ב: | Mol Pharm |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6466629/ https://ncbi.nlm.nih.gov/pubmed/29356543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.molpharmaceut.7b00802 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|